147 related articles for article (PubMed ID: 7706163)
21. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Hybenová D; Majtán V
Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
[TBL] [Abstract][Full Text] [Related]
22. The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility.
MacGowan AP; Wootton M; Holt HA
J Antimicrob Chemother; 1999 Mar; 43(3):345-9. PubMed ID: 10223589
[TBL] [Abstract][Full Text] [Related]
23. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa.
Boswell FJ; Andrews JM; Wise R
J Antimicrob Chemother; 1997 Jun; 39(6):811-4. PubMed ID: 9222052
[TBL] [Abstract][Full Text] [Related]
24. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
[TBL] [Abstract][Full Text] [Related]
25. The effect of pharmacokinetics on the bactericidal activity of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae and the emergence of resistance.
Thorburn CE; Edwards DI
J Antimicrob Chemother; 2001 Jul; 48(1):15-22. PubMed ID: 11418508
[TBL] [Abstract][Full Text] [Related]
26. Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.
Carbone M; Pennisi MG; Masucci M; De Sarro A; Giannone M; Fera MT
Vet Microbiol; 2001 Jul; 81(1):79-84. PubMed ID: 11356321
[TBL] [Abstract][Full Text] [Related]
27. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
Odenholt-Tornqvist I; Löwdin E; Cars O
Antimicrob Agents Chemother; 1992 Sep; 36(9):1852-8. PubMed ID: 1329631
[TBL] [Abstract][Full Text] [Related]
28. Postantibiotic effects of E-4868 and OPC-17116.
Sanford MD; Jones RN
J Antimicrob Chemother; 1993 Dec; 32(6):916-7. PubMed ID: 8144440
[No Abstract] [Full Text] [Related]
29. Bacterial strain-independent AUC/MIC and strain-specific dose-response relationships reflecting comparative fluoroquinolone anti-pseudomonal pharmacodynamics in an in vitro dynamic model.
Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2002 Jul; 20(1):44-9. PubMed ID: 12127710
[TBL] [Abstract][Full Text] [Related]
30. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Hoogkamp-Korstanje JA
J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
[TBL] [Abstract][Full Text] [Related]
31. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
Pruul H; McDonald PJ
J Antimicrob Chemother; 1990 Jan; 25(1):91-101. PubMed ID: 2108116
[TBL] [Abstract][Full Text] [Related]
32. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
Mayer I; Nagy E
APMIS; 2000 Apr; 108(4):261-6. PubMed ID: 10843412
[TBL] [Abstract][Full Text] [Related]
34. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
Louie A; Baltch AL; Ritz WJ; Smith RP
Chemotherapy; 1991; 37(4):275-82. PubMed ID: 1665123
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
[TBL] [Abstract][Full Text] [Related]
37. [Bactericidal activity of ciprofloxacin and sparfloxacin. Comparison with others active antibiotics against Pasteurella multocida].
Gastine C; Donnio PY; Travert MF; Avril JL
Presse Med; 1995 Mar; 24(11):519-22. PubMed ID: 7770389
[TBL] [Abstract][Full Text] [Related]
38. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
Horgen L; Legrand E; Rastogi N
Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
Malmborg AS; Ahlén S
Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
[TBL] [Abstract][Full Text] [Related]
40. Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
Bedard J; Chamberland S; Wong S; Schollaardt T; Bryan LE
Antimicrob Agents Chemother; 1989 Sep; 33(9):1457-64. PubMed ID: 2510591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
